ArticleCancers2023

Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients.

Ting-Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.